ProfileGDS5822 / ILMN_1242233
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 98% 97% 97% 98% 97% 98% 97% 98% 98% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 14116.498
GSM1276600PDAC Late Ablation Control 21956.297
GSM1276601PDAC Late Ablation Control 32196.197
GSM1276602PDAC Late Ablation 13188.698
GSM1276603PDAC Late Ablation 22225.697
GSM1276604PDAC Late Ablation 32847.698
GSM1303940PDAC Late Ablation_anti-CTLA4 12210.497
GSM1303941PDAC Late Ablation_anti-CTLA4 2270198
GSM1303942PDAC Late Ablation_anti-CTLA4 32983.598